Linear '2-0-1' lymphocyte development: Hypotheses on cellular bases for immunity

Trends in Immunology

Volumn 24, Issue 5, 2003, Pages 235-241

  Perussia, Bice ^a   Loza, Matthew J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CYTOKINE; GAMMA INTERFERON; T LYMPHOCYTE RECEPTOR; VACCINE;

AUTOIMMUNITY; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CELL TYPE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

EID: 0037725220     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00080-2     Document Type: Review

References (44)

1. Mossman T.R., Sad S. The expanding universe of T cell subsets: Th1, Th2, and more. Immunol. Today. 17:1996;138-146.
2. Jankovic D., et al. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol. 22:2001;450-457.
3. Hendriks R.W., et al. Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur. J. Immunol. 29:1999;1912-1918.
4. Rosmaraki E.E., et al. Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 31:2001;1900-1909.
5. Ting C.N., et al. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature. 384:1996;474-478.
6. Van Esch H., et al. GATA3 haplo-insufficience causes human HDR syndrome. Nature. 406:2000;419-422.
7. + NK cells and regulation of their pool size by IL-4. Eur. J. Immunol. 32:2002;413-423.
8. -/lo T cell development from type 2 to type 1 cytokine production. J. Immunol. 169:2002;3061-3068.
9. Loza M.J., Perussia B. Final steps of natural killer cells maturation: a general model for type 1-type 2 differentiation? Nat. Immunol. 2:2001;917-924.
10. Loza M.J., Perussia B. Accumulation of type 2 cytokine+ T cells depends on differentiation-independent proliferation of pre-existing type 2 T cells. Eur. J. Immunol. 33:2003;939-949.
11. Loza M.J., et al. NKT and T cells: Coordinate regulation of NK-like phenotype and cytokine production. Eur. J. Immunol. 32:2002;3453-3462.
12. + T helper cell phenotype development in a T-cell receptor-α β-transgenic model. J. Exp. Med. 182:1995;1579-1584.
13. Murphy E., et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:1996;901-913.
14. Smits H.H., et al. IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. Eur. J. Immunol. 31:2001;1055-1065.
15. D'Andrea A., et al. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL- 13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J. Exp. Med. 181:1995;537-546.
16. Trinchieri G. Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection. J. Exp. Med. 194:2001;F53-F57.
17. Roman E., et al. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196:2002;957-968.
18. Poulendran B., et al. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 22:2001;41-46.
19. Borrego F., et al. Structure and function of major histocompatibility complex (MHC) class I specific receptor expressed on human natural killer (NK) cells. Mol. Immunol. 38:2002;637-660.
20. Rogge L., et al. Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat. Genet. 25:2000;96-101.
21. Pien G.C., et al. A unique mechanisms for innate cytokine promotion of T cell responses to viral infection. J. Immunol. 169:2002;5827-5837.
22. Tough D.F., et al. Induction of bystander T cell proliferation by viruses and type 1 interferon in vivo. Science. 272:1996;1947-1950.
23. Chen W., et al. TGF-β release by apoptotic T cells contributes to an immunosuppressive milieu. Immunity. 14:2001;715-725.
24. Sallusto F., et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:1999;708-712.
25. Brombacher, F. et al. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. (in press).
26. Robinson D.S., O'Garra A. Further checkpoints in Th1 development. Immunity. 16:2002;755-758.
27. Belkaid Y., et al. The role of Interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:2001;1497-1506.
28. Benlagha K., et al. A thymic precursor to the NKT cell lineage. Science. 296:2002;553-555.
29. Leclercq G., et al. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential natural killer progenitor cells. J. Exp. Med. 184:1996;325-336.
30. Benriss-Vermare N., et al. Human thymus contains IFN-α-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J. Clin. Invest. 107:2001;835-844.
31. Kikkawa E., et al. Th1/Th2 cell differentiation of developing CD4 single-positive thymocytes. Int. Immunol. 14:2002;943-951.
32. Stein-Streilein J., Streilein J.W. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int. Rev. Immunol. 21:2002;123-152.
33. Wells A.D., et al. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J. Clin. Invest. 108:2001;895-903.
34. Tominaga N., et al. Development of Th1 and notTh2 immune responses in mice lacking IFN-regulatory factor-4. Int. Immunol. 15:2003;1-10.
35. Bird J.J., et al. Helper T cell differentiation is controlled by the cell cycle. Immunity. 9:1998;229-237.
36. Kamogawa Y., et al. The relationship of IL-4 and IFN-γ-producing T cells studied by ablation of IL-4-producing cells. Cell. 75:1993;985-995.
37. Ortmann R., et al. A heritable defect in IL-12 signaling in B10.Q/J mice. In vitro studies. J. Immunol. 166:2001;5712-5719.
38. + T cells during a Th2 response in Leishmania major-infected mice. Eur. J. Immunol. 30:2000;2007-2014.
39. Hoffmann K.F., et al. Studies with double cytokine-deficient mice reveal that highly polarized Th1 and Th1-type cytokine and antibody responses contribute equally to induced immunity in Schistosoma mansoni. J. Immunol. 163:1999;927-938.
40. Schuler T., et al. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin4-deficienet mice. J. Exp. Med. 189:1999;803-810.
41. Bass H., et al. Evidence for mouse Th1- and Th2-like helper T cells in vivo. Selective reduction of Th1-like cells after total lymphoid irradiation. J. Exp. Med. 170:1989;1495-1511.
42. Biedermann T., et al. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat. Immunol. 2:2001;1054-1060.
43. + T-cell responses against malaria liver stages. Nat. Med. 8:2002;166-170.
44. Roncarolo M.G., et al. Type 1 regulatory cells. Immunol. Rev. 182:2001;68-79.